Levothyroxine - NDC Database (Page 48)
70710-1833 Nov 01, 2024
Levothyroxine Sodium 100 ug/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Zydus Pharmaceuticals USA Inc.
Levothyroxine Sodium 100 ug/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Zydus Pharmaceuticals USA Inc.
70710-1834 Nov 01, 2024
Levothyroxine Sodium 200 ug/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Zydus Pharmaceuticals USA Inc.
Levothyroxine Sodium 200 ug/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Zydus Pharmaceuticals USA Inc.
70710-1835 Nov 01, 2024
Levothyroxine Sodium 500 ug/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Zydus Pharmaceuticals USA Inc.
Levothyroxine Sodium 500 ug/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Zydus Pharmaceuticals USA Inc.
70771-1818 Nov 01, 2024
Levothyroxine Sodium 100 ug/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Zydus Lifesciences Limited
Levothyroxine Sodium 100 ug/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Zydus Lifesciences Limited
70771-1819 Nov 01, 2024
Levothyroxine Sodium 200 ug/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Zydus Lifesciences Limited
Levothyroxine Sodium 200 ug/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Zydus Lifesciences Limited
70771-1820 Nov 01, 2024
Levothyroxine Sodium 500 ug/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Zydus Lifesciences Limited
Levothyroxine Sodium 500 ug/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Zydus Lifesciences Limited
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.